Microbot Medical Inc. (LS:A2N5AS) Financings
Financings
| Raise | Date |
|---|---|
| Warrant exercise of common shares on exercise of outstanding preferred investment options Closed: US$2.8M in the latest tranche · US$2.1 a share · Warrants at US$4.5 for 24 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Development, commercialization and regulatory work for the LIBERTY Robotic System, potential acquisitions, new applications, working capital | Oct 7, 2025 |
| Registered direct offering of common stock with concurrent private placement of short-term series I preferred investment options Closed: US$13M raised · US$2.13 a share · Warrants at US$2.13 for 24 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Development, commercialization and regulatory work for the LIBERTY Robotic System, new applications from its IP, working capital and general corporate purposes | Feb 11, 2025 |
| Registered direct offering of common stock with concurrent private placement of short-term series H preferred investment options Closed: US$8.6M raised · US$2.27 a share · Warrants at US$2.1 for 24 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Development, commercialization and regulatory activities for the LIBERTY Robotic System, new applications from its IP, working capital and general purposes | Jan 10, 2025 |
| Registered direct offering of common stock with concurrent private placement of short-term series G preferred investment options Closed: US$7M raised · US$1.75 a share · Warrants at US$1.75 for 24 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Development, commercialization and regulatory activities for the LIBERTY Robotic System, new applications from its IP, working capital and general corporate purposes | Jan 7, 2025 |
| At-the-market programme of common stock Tranche closed: US$4.8M raised | Jan 7, 2025 |